Navigation Links
AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles

rapeutic approaches that add to the breadth and depth of our product pipeline," said Dr Jurgen Engel, Executive Vice President, Global R&D and Chief Operating Officer at AEterna Zentaris. "The potential for cancer treatment with agents inhibiting the PI3K pathway has become a focus in recent drug discovery and development research. We believe that by developing novel selective PI3K inhibiting small molecular compounds, we are positioning ourselves as one of the leaders in this promising therapeutic approach."

Cellular substrate phosphorylation studies targeting the inhibition of PI3K and functional cellular assays of tumor cell proliferation have been performed. In addition, physicochemical and initial ADMET data were collected. Several derivatives are currently undergoing first pharmacokinetic in vivo studies.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a global, pure play biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization.

News releases and additional information are available at www.aeternazentaris.com

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "believes", "anticipates", "intends", "plans", "expects", "estimates", "will," "may", "should", "approximately", and the negative or other variations of those terms or comparable terminology, are forward-looking statements. Such statements reflect management's current views, intentions, strategies and plans and are based on certain assumptions.

Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual res
'"/>




Page: 1 2 3

Related medicine technology :

1. AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting
2. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
3. AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist JMR-132 at the AACR Annual Meeting in Los Angeles
4. AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors and In Vivo Results for a GHRH Antagonist at the AACR Annual Meeting in Los Angeles
5. AEterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial
6. terna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
9. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
10. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
11. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
Post Your Comments:
(Date:5/23/2013)... 2013  Spring Bank Pharmaceuticals, Inc., a biopharmaceutical company ... today announced that it has initiated dosing in a ... daily, oral therapy for the treatment of HCV infection. This ... is designed to assess both the safety and antiviral ... drug for the treatment of chronic HCV infections and ...
(Date:5/23/2013)...  Net Medical Xpress Solutions, Inc., (OTC QB: NMXS), ... company has signed a letter of intent to acquire ... Huntsville, AL . MedTel Solutions is a ... recruitment of telemedicine physicians. Consideration for the acquisition will ... is expected by June 30, 2013. Dick ...
(Date:5/23/2013)... Conn. , May 23, 2013  CAS Medical Systems, ... medical devices for non-invasive patient monitoring, today announced that ... Officer,  will present at the 2 nd Annual Marcum ... Hyatt Hotel in New York City . ... p.m. ET in the Estate 10 room and will be ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2
(Date:5/24/2013)... (PRWEB) May 24, 2013 ... of the latest update involving allegations that the ... SR (azithromycin) can allegedly cause potentially fatal ... reported on May 17, 2013* that Health Canada ... in warning that Zithromax can cause abnormal changes ...
(Date:5/24/2013)... Wisconsin (PRWEB) May 24, 2013 Scott ... younger brother, Troy Tischler, lose 200 lbs. of fat ... Ryan Tischler teach his younger brother the importance of ... healthy diet. By sticking to these 7 rules of ... weight loss goals can be accomplished. , 1.    Find a ...
(Date:5/24/2013)... Los Angeles,Ca (PRWEB) May 24, 2013 ... and women courtesy of Dermasis.com. This new FDA registered ... ease the itching, burning and appearance of Psoriasis infected ... cream for men and women online. This soothing cream ... suffer from the burning, flaking and appearance of red ...
(Date:5/23/2013)... St. Petersburg, FL (PRWEB) May 24, 2013 ... anti-cellulite products, the Cellulite Whisperer line, ... "Get Ready for Summer Sale" includes two proprietary ... Cellulite Whisperer® Lotion . , Purchasers receive ... a bonus. , "The Gel has a wonderful ...
(Date:5/23/2013)... Internationally recognized as one of the top ... 29 years, Coach Nick Saviano’s proven methodology ... Grand Slam winners, World #1’s; Junior Wimbledon, US Open, ... Junior Champions, 8 Foreign National Junior Champions and more ... Bowl and Eddie Herr winners - and boasts a ...
Breaking Medicine News(10 mins):Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 2Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 3Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 4Health News:Dermasis Psoriasis Treatment Cream for Men and Women Released Online at HealthCareSupplementz.com 2Health News:Fresh Organics in the New Cellulite Whisperer® Products from Sublime Beauty®; "Get Ready for Summer Sale" Continues 2Health News:Internationally Respected Tennis Coach, Nick Saviano Opens Summer Training Registration 2
... , SAN DIEGO, Dec. 11 ... of post-secondary education services focused on providing higher access to ... graduate school specializing in psychology programs at the master,s and ... in Career Management and Counseling. , This specialization responds ...
... , ... shareholders and followers of HTDS , SHENZHEN, China, Dec. 11 /PRNewswire-FirstCall/ - ... asked to comment on recent activity in its stock price. First, we ... fact that there is no news that they do not know about. ...
... ... Corporation from Chinese Principals! , ... (PRWEB) December 11, 2009 -- In August, 2004 U.S. Shanghai Chemical Corporation, a New Jersey ... a reverse merger. Principals of the Chinese company were elected to the Board of Directors ...
... ... list of “Ten Best Staffing Firms to Work For,” published earlier this month in ... ... a premier research and analysts firm, surveys companies in the contingent staffing industry to ...
... , SALINAS, Calif., Dec. 10 A precautionary voluntary ... Salad has been issued by California-based organicgirl Produce because it ... for walnuts. , People who have an allergy ... or life-threatening allergic reaction if they consume this product. , ...
... , , NEW YORK, Dec. 10 ... (MRI) announced today that they have integrated NMI,s LOHAS consumer ... database. , LOHAS is an ... system that classifies consumers according to their behaviors and attitudes ...
Cached Medicine News:Health News:Bridgepoint Education's University of the Rockies Introduces New Master of Arts Specialization in Career Management and Counseling 2Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 2Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 3Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 4Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 5Health News:Hard to Treat Diseases (HTDS) Comments on Recent Movement Of Its Security 6Health News:New Board Gains Control of U.S. Shanghai Chemical Corporation 2Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 2Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 3Health News:Jackson & Coker Ranks #3 among “Ten Best Staffing Firms to Work For” 4Health News:MRI Partners with Natural Marketing Institute 2Health News:MRI Partners with Natural Marketing Institute 3Health News:MRI Partners with Natural Marketing Institute 4
100% Silicone Foley Catheter Kits 2-Way...
Coude Foley Catheters (Latex) 2-Way Red...
Silicone Elastomer-Coated Latex Foley Catheters 2-Way...
Silicone Foley Catheters 2-Way (Pediatric)...
Medicine Products: